>Global sales for March 2024 at +15.2% y-o-y (vs +16.4% in February), Q1 2024 at +15% - Worldwide semiconductor sales in March 2024 were published by the WSTS (World Semiconductor Trade Statistics), with the usual one-month lag. In terms of the three-month moving average, sales came to $ 50.8bn, falling short of our estimate of $ 52.2bn, pointing to y-o-y growth +15.2% (a slight sequential decline of -0.6%). This marks a slowdown vs February, which stood at +16.4%. Q1...
>microLED restructuring means lower revenue growth prospects, but also improved mid-term cash flow and potential transfer of a lease - In late February 2024, ams OSRAM announced the unexpected cancellation of a key project underpinning its microLED strategy. On one hand, the group lost a major revenue growth driver and it now expects a revenue CAGR of 6-8% for the period 2023-2026 compared with 6-10% previously. On the other hand, the exit from microLED will remove ...
>microLED restructuring means lower revenue growth prospects, but also improved mid-term cash flow and potential transfer of a lease - In late February 2024, ams OSRAM announced the unexpected cancellation of a key project underpinning its microLED strategy. On one hand, the group lost a major revenue growth driver and it now expects a revenue CAGR of 6-8% for the period 2023-2026 compared with 6-10% previously. On the other hand, the exit from microLED will remove ...
>Ventes mondiales de mars 2024 à +15.2% yoy (vs +16.4% en février), un T1 24 à +15% - Les ventes mondiales de semiconducteurs de mars 2024 ont été publiées par la WSTS (World Semiconductor Trade Statistics), avec comme toujours, un mois de décalage. En données lissées (moyenne 3 mois), elles ressortent à 50.8 Md$, inférieures à notre prévision à 52.2 Md$, en croissance annuelle de 15.2% (légère baisse en séquentiel de -0.6%). Il s’agit d’un ralentissement par rapport ...
>The real question with the release is the guidance, not the figures themselves - Infineon is set to report its Q2 2024 results on Tuesday morning before trading, with a conference call at 9.30 a.m. CET. We expect results to be slightly ahead of the consensus thanks notably to a €/$ exchange rate that is slightly more favourable than anticipated, but that is not the main question. The real question with this release will be the 2024 guidance which in our view (and now...
>Outperform rating confirmed – target price lifted to € 4.2 (vs € 4.0) - Q1 2024 results underpin our Outperform recommendation, with a reassuring trend on the key operating points (NII momentum, control of costs and moderate CoR), and ultimately on capital/shareholder returns. The group reiterated its guidance on 2024 (net profit > € 8bn in 2024 and 2025 vs € 7.7bn in 2023) notably thanks to its highly diversified business model (revenues linked to long-term savings)...
>Opinion Surperformance confortée – OC porté à 4.2 € (vs 4.0 €) - Le T1 2024 vient conforter notre opinion Surperformance avec une évolution rassurante sur les points clés opérationnels (momentum NII, maîtrise des coûts & niveau modéré de CdR), et in fine sur le capital/retour à l’actionnaire. Le groupe réitère ses guidances pour 2024 (RN > 8 Md€ en 2024 & 2025 vs 7.7 Md€ en 2023), ce que nous validons grâce au business model très diversifié (revenus liés à l’épargne ...
>La vraie question de la publication est la guidance, pas les chiffres eux-mêmes - Infineon publiera ses résultats T2 24 mardi matin avant l’ouverture, avec une conférence call à 9.30 CET. Nous attendons des résultats légèrement au-dessus des attentes du consensus notamment grâce à un forex €/$ un peu plus favorable qu’anticipé, mais ce n’est pas le sujet important. Le véritable enjeu de cette publication sera la guidance 2024 qui, selon nous (et désormais le consensu...
PARIS--(BUSINESS WIRE)-- Regulatory News: Clariane (Paris:CLARI) (CLARIA.PA – ISIN FR0010386334) annonce avoir renouvelé ce jour le tirage de sa ligne de RCF (Revolving Credit Facility) pour une période de 6 mois (échéance au 3 novembre 2024) pour un montant de 492,5 millions d’euros, conformément aux termes prévus au contrat signé en 2019 et étendu le 25 juillet 2023. Le Groupe rappelle que le tirage et le renouvellement de sa ligne de RCF sont conditionnés, outre les conditions usuelles, à un niveau de liquidité minimum de 300 millions d’euros au jour dudit tirage ou renouvellement, lequ...
Rdos. 1T'24 vs 1T'23: M. Intereses: 3.932 M euros (+20,8% vs +19,9% BS(e) y +20,5% consenso); M. Bruto: 6.732 M euros (+11,1% vs +8,4% BS(e) y +9,2% consenso); M. Neto: 4.162 M euros (+18,2% vs +9,8% BS(e) y +11,8% consenso); BDI: 2.301 M euros (+17,6% vs +13,4% BS(e) y n/a consenso). Rdos. 1T'24 vs 4T'23: M. Intereses: 3.932 M euros (-1,6% vs -2,4% BS(e) y -1,9% consenso); M. Bruto: 6.732 M euros (+5,6% vs +3,0% BS(e) y +3,8% consenso); M. Neto: 4.162 M euros (+43,3% vs +33,1% BS(e) y +35,6% co...
Founded in 1959, Leifheit AG is one of the leading European brand suppliers of household items. The group divides its operating business into the household, wellbeing and private label segments. In view of its growing turnover (CAGR of +2.8% for 2023 to 2026e) and EBIT margins (+290bp to 5.2% in 2026e vs 2023), as well as its solid financial profile (equity ratio of about 50%, average net cash position of c. € 40m for 2024e to 2026e, average positive FCF of c. € 11m for 2024e to 2026e...
Founded in 1959, Leifheit AG is one of the leading European brand suppliers of household items. The group divides its operating business into the household, wellbeing and private label segments. In view of its growing turnover (CAGR of +2.8% for 2023 to 2026e) and EBIT margins (+290bp to 5.2% in 2026e vs 2023), as well as its solid financial profile (equity ratio of about 50%, average net cash position of c. € 40m for 2024e to 2026e, average positive FCF of c. € 11m for 2024e to 2026e...
>Q1 revenue: robust organic growth - LNA Santé has reported Q1 revenue of € 189.3m, up 6.9% (+6.9% l-f-l). Occupancy rates at cruising speed, excl. hospital care at home, stood at 99%, up 1.6 points vs Q1 2023. LNA reiterated its target for organic growth of 4.5%, i.e. operating income of >€ 750m (i.e. >+4.2%) for an EBITDA margin excl. IFRS of 11% (vs 10.8% in 2023). That said, LNA noted the latest elements relating to 1/ the 2024 tariff campaign for post-acute/...
>CA T1 : une croissance organique robuste - LNA Santé publie un CA T1 à 189,3 M€, une hausse de 6,9% (+6,9% à ptc.). Le taux d’occupation des établissements en régime de croisière, hors HAD, ressort à 99%, en hausse de 1,6 point par rapport au T1 2023. LNA renouvelle son objectif de croissance organique à 4,5% soit un CA Exploitation de >750 M€ (ie. >+4,2%) pour une marge d’EBITDA hors IFRS à 11% (vs 10,8% en 2023). Toutefois, LNA insiste sur les derniers élément...
BHP's bid for Anglo American has confirmed interest from miners in copper in the context of increasingly challenged production and difficulties in fully completing projects. Anglo’s (Neutral) prospects in copper are now better valued and this is also the case for BHP (Neutral vs Underperform) although not so for Rio Tinto (Outperform vs Neutral). Downstream, Nexans and Montana Aerospace are our Top Picks (Outperform) vs Aurubis, Rexel and Prysmian (Neutral). - >Our copper ...
L’offre de BHP sur Anglo American a confirmé l’intérêt des minières pour le cuivre dans un contexte de tensions croissantes sur la production et de difficultés à faire aboutir les projets. Les perspectives d’Anglo (Neutre) dans le cuivre sont désormais mieux valorisées, c’est aussi le cas de BHP (Neutre vs Sous-performance) mais pas encore assez, selon nous, sur Rio Tinto (Surperformance vs Neutre). En aval, Nexans et Montana Aerospace sont nos valeurs préférées (Surperformance) ...
Deutz is a leading non-captive engine manufacturer for a wide range of customer industries with a strong and very well-known brand. The company will enter a profitable growth period soon (CAGR 2023-26e sales 8%, EPS 18%). We initiate coverage with an Outperform rating and a target price of € 7.9, reflecting >40% upside from here. - ...
Deutz is a leading non-captive engine manufacturer for a wide range of customer industries with a strong and very well-known brand. The company will enter a profitable growth period soon (CAGR 2023-26e sales 8%, EPS 18%). We initiate coverage with an Outperform rating and a target price of € 7.9, reflecting >40% upside from here. - ...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.